about
Survivin as prognostic and predictive factor in patients treated with gemcitabine, dexamethasone, and cisplatin for relapsed or refractory aggressive NHL.Automated mass action model space generation and analysis methods for two-reactant combinatorially complex equilibriums: an analysis of ATP-induced ribonucleotide reductase R1 hexamerization data.Profiling ribonucleotide and deoxyribonucleotide pools perturbed by gemcitabine in human non-small cell lung cancer cells.Investigation of reactions postulated to occur during inhibition of ribonucleotide reductases by 2'-azido-2'-deoxynucleotidesReactions of Trimethylsilyl Fluorosulfonyldifluoroacetate with Purine and Pyrimidine Nucleosides.
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Gemcitabine (Gemzar) in non-small cell lung cancer.
@ast
Gemcitabine (Gemzar) in non-small cell lung cancer.
@en
type
label
Gemcitabine (Gemzar) in non-small cell lung cancer.
@ast
Gemcitabine (Gemzar) in non-small cell lung cancer.
@en
prefLabel
Gemcitabine (Gemzar) in non-small cell lung cancer.
@ast
Gemcitabine (Gemzar) in non-small cell lung cancer.
@en
P2860
P356
P1476
Gemcitabine (Gemzar) in non-small cell lung cancer.
@en
P2093
Christian Manegold
P2860
P304
P356
10.1586/14737140.4.3.345
P577
2004-06-01T00:00:00Z